Visiongain Report Provides Critical Market-led Data on the $48bn Antibacterial Drugs Market

Global Antibacterial Drugs Market 2019-2029

Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others

News provided by

Jun 24, 2019, 05:00 ET

LONDON, June 24, 2019 /PRNewswire/ -- The global antibacterial drugs market is estimated to have reach $43bn in 2018 and is expected to grow at a CAGR of 2% in the first half of the forecast period. The Cephalosporins submarket held 28% of the global antibacterial drugs market in 2018.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new Visiongain report you will receive 144 tables and 105 figures– all unavailable elsewhere.

The 297-page report provides clear detailed insight into the global antibacterial drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-antibacterial-drugs-market-2019-2029/#download_sampe_div

Report Scope

• Global Antibacterial Drugs Market forecasts from 2019-2029

• Revenue forecasts for the 6 leading submarkets from 2019-2029:
• Cephalosporins
• Penicillins
• Fluoroquinolones
• Macrolides
• Carbapenems
• Others

• Revenue forecasts for the 43 leading marketed antibacterial drugs from 2019-2029:
• Cephalosporins: Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam
• Penicillins: Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic amoxicllin-clavulanic acid, Amoxil
• Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, Cipro/Ciprobay, Geninax, Defafloxacin
• Macrolides: Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin
• Carbapenems: Invanz, Merrem/Meropen, Primaxin, Doribax
• Other antibacterial drugs: Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin

• Revenue forecasts for the leading regional markets forecasted in this report are the following:
• North America
• Europe
• Asia-Pacific
• RoW

Each regional market is further segmented by the 6 leading submarkets.

• Revenue forecasts for the leading national markets forecasted in this report are the following:
• The US
• Japan
• Italy
• France
• The UK
• Spain
• Germany
• China
• India
• Brazil
• Russia
• South Korea

• This report discusses the selected leading companies:
• Adenium Biotech ApS,
• Allecra Therapeutics GmbH
• AstraZeneca
• Bayer
• BioVersys AG
• Eli Lilly
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis
• Pfizer

• Analysis of the strengths, weaknesses as well as the opportunities and threats of the antibacterial drugs industry and market

• Coverage of antibacterial drug candidates in the R&D pipeline. Discussions of research and development – see progress in this industry, finding technological, clinical and commercial outlooks and opportunities

• Key Questions Answered by this Report:
• Gain forecasts from 2019 to 2029 for the overall world market and its leading submarkets, as well as those for prominent national markets.
• Explore the regulatory landscape for leading regional and national markets, as well as expected developments for the period 2019-2029.
• Identify drug development trends that will affect market participants from 2019 to 2029. This report contains SWOT and STEP analysis for the forecast period.
• See discussions of companies developing, manufacturing and marketing antibiotics, exploring products, technologies, R&D, partnerships, M&A and outlooks.

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-antibacterial-drugs-market-2019-2029/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

Abbott Laboratories
AbbVie
Achaogen
Actavis
Actelion
Affinium Pharmaceutical
AiCuris GmbH & Co. KG
Alcon
Alkem Laboratories
Allergan
Allied Pharma
Apotex
APP Pharmaceuticals
Aptalis Pharma
Aquapharm Biodiscovery
Aradigm
Aridis Pharmaceuticals
Ascend Therapeutics
Astellas Pharma
AstraZeneca
Aurobindo Pharma
Barr Pharmaceuticals
Basilea Pharmaceuticals
Bayer Laboratories
Biomax Biotechnics
Bristol-Myers Squibb
Cadila Healthcare
Calixa Therapeutics
Cardeas Pharma
Cellceutix
Cempra Pharmaceuticals
Cipla
Claris Lifesciences
Cornerstone Biopharma
Cornerstone Therapeutics
Corona Remedies
Critical Therapeutics
Cubist Pharmaceuticals
Daiichi Sankyo
Dainippon Sumitomo
Discuva
Dr. Reddy's Laboratories
Durata Therapeutics
Eli Lilly
Emcure Pharmaceuticals
Eros Pharma
Forest Laboratories
Furiex Pharmaceuticals
Gate Pharma
Gilead Sciences
Glenmark
GlycoVaxyn
GlaxoSmithKline (GSK)
Hetero
Hi-Tech Pharma
Hikma Farmaceutica
Hospira
Insmed
Intercell
Itochu Chemical Frontier
Janssen Pharmaceuticals
Johnson & Johnson
KaloBios
Kenta Biotech
Kuhnil Pharm
Lupin
Macleod Pharmaceuticals
Medicis
MedImmune
Meiji
Melinta Therapeutics
Merck & Co.
Merlion Pharmaceuticals
Microlabs
MicuRx Pharmaceuticals
Mpex Pharmaceuticals
Mylan
Nabriva Therapeutics
Nalneva
Neiss Labs
Nektar Therapeutics
Novacta Biosystems
Novartis
Novexel
Optimer Biotechnology
Orchid Chemicals
Orchid Healthcare
Ortho-McNeil
Paratek Pharmaceuticals
Peninsula Pharmaceuticals
Pfizer
Pharmacia
Phico Therapeutics
Piramal Healthcare
Plenus Pharmaceuticals
Pliva
Polyphor
Procarta Biosystems
Procter & Gamble Pharmaceuticals
Ranbaxy
Redx Pharma
Roche
Roxane
R-Pharma
Sagent Pharmaceuticals
Sandoz
Sanofi
Savara Pharmaceuticals
Sawai Pharmaceutical
Schering Plough
Seika Pharma
Sequella
Shanghai MengKe Pharmaceuticals
Shionogi
Shire
Sidmak Labs
Solitaire Pharmacia
Specialised Therapeutics Australia
Sunovion Pharma
TaiGen Biotechnology
Taisho Toyama
Takeda
TAP Holdings
Targanta Therapeutics
Tetraphase Pharmaceuticals
Teva Pharmaceutical Industries
The Medicines Company
Theravance
Torrent Pharmaceuticals
Trius Therapeutics
TTY Biopharma
Unichem Laboratories
Valeant Pharmaceuticals
Vansen Pharma
ViroPharma
Warner Chilcott
Watson
Wockhardt
Zhejiang Medicine Company
Zuellig Pharma
Zydus Pharmaceuticals

List of Organisations Mentioned in the Report
Agência Nacional de Vigilância Sanitária (ANVISA)
Duke University
European Medicines Agency (EMA)
Food and Drug Administration (FDA)
Ministry of Health, Labour and Welfare (MHLW)
Michigan State University
National Institute for Health and Clinical Excellence (NICE)
National Institutes of Health (NIH)
University of Connecticut
World Health Organization (WHO)